Urine flow acceleration is superior to Qmax in diagnosing BOO in patients with BPH

Abstract

We performed a retrospective, case-control study to evaluate whether the urine flow acceleration (UFA, mL/s²) is superior to maximum uroflow (Qmax, mL/s) in diagnosing bladder outlet obstruction (BOO) in patients with benign prostatic hyperplasia (BPH). In this study, a total of 50 men with BPH (age: 58±12.5 years) and 50 controls (age: 59±13.0 years) were included. A pressure-flow study was used to determine the presence of BOO according to the recommendations of Incontinence Control Society (ICS). The results showed that the UFA and Qmax in BPH group were much lower than those in the control group [(2.05±0.85) vs. (4.60±1.25) mL/s² and (8.50±1.05) vs. (13.00±3.35) mL/s] (P<0.001). According to the criteria (UFA<2.05 mL/s², Qmax<10 mL/s), the sensitivity and specificity of UFA vs. Qmax in diagnosing BOO were 88%, 75% vs. 81%, 63%. UFA vs. Omax, when compared with the results of P-Q chart (the kappa values in corresponding analysis), was 0.55 vs. 0.35. The prostate volume, post void residual and detrusor pressure at Qmax between the two groups were 28.6±9.8 vs. 24.2±7.6 mL, 60.4±1.4 vs. 21.3±2.5 mL and 56.6±8.3 vs. 21.7±6.1 cmH₂O, respectively (P<0.05). It was concluded that the UFA is a useful urodynamic parameter, and is superior to Qmax in diagnosing BOO in patients with BPH.

Keywords

benign prostate hyperplasia (BPH) / bladder outlet obstruction (BOO) / urine flow acceleration (UFA) / Qmax / P-Q chart

References

[1] CabelinMA, TeAE, KaplanSA. Benign prostatic hyperplasia: Challenges for the new millennium. Curr Opin Urol, 2000, 10(4): 301-306

[2] ChoKS, KimJH, KimDJ, et al.. Relationship between prostatic urethral angle and urinary flow rate: its implication in benign prostatic hyperplasia pathogenesis. Urology, 2008, 71(5): 858-862

[3] KuJH, KoDW, ChoJY, et al.. Correlation between prostatic urethral angle and bladder outlet obstruction index in patients with lower urinary tract symptoms. Urology, 2010, 75(6): 1467-1471

[4] KojimaM, InuiE, OchiaiA, et al.. Noninvasive quantitative estimation of infravesical obstruction using ultrasonic measurement of bladder weight. J Urol, 1997, 157(2): 476-479

[5] OelkeM, HöfnerK, JonasU, et al.. Diagnostic accuracy of noninvasive tests to evaluate bladder outlet obstruction in men: detrusor wall thickness, uroflowmetry, post void residual urine, and prostate volume. Eur Urol, 2007, 52(3): 827-834

[6] BruskewitzRC, IversenP, MadsenPO, et al.. Value of post void residual urine determination in evaluation of prostatism. Urology, 1982, 20(6): 602-604

[7] KranseR, Van MastrigtR. Weak correlation between bladder outlet obstruction and probability to void to completion. Urology, 2003, 62(4): 667-671

[8] BelalM, AbramsP. Noninvasive methods of diagnosing bladder outlet obstruction in men. Part 1: Nonurodynamic approach. J Urol, 2006, 176(1): 22-28

[9] BelalM, AbramsP. Noninvasive methods of diagnosing bladder outlet obstruction in men. Part 2: Noninvasive urodynamics and combination of measures. J Urol, 2006, 176(1): 29-35

[10] PelJJ, BoschJL, BlomJH, et al.. Development of a non-invasive strategy to classify bladder outlet obstruction in male patients with LUTS. Neurourol Urodyn, 2002, 21(2): 117-125

[11] OhMM, KimJW, KimJJ, et al.. Is there a correlation between the outcome of transurethral resection of prostate and preoperative degree of bladder outlet obstruction?. Asian J Androl, 2012, 14(4): 556-559

[12] ImaiT, SatohK, ManabeN, et al.. New parameters “average flow” and “acceleration wave”: comparison with current parameters in the flow volume curve. Rinsho Byori, 2011, 59(5): 459-465

[13] AbramsP, CardozoL, FallM, et al.. The standardization of terminology of lower urinary tract function: report from the Standardisation Sub-committee of the International Continence Society. Neurourol Urodyn, 2002, 21(2): 167-178

[14] BarkinJ. Benign prostatic hyperplasia and lower urinary tract symptoms: evidence and approaches for best case management. Can J Urol, 2011, 18(Suppl): 14-19

[15] DonnellRF. Benign prostate hyperplasia: a review of the year’s progress from bench to clinic. Curr Opin Urol, 2011, 21(1): 22-26

[16] ButtyanR, ChenMW, LevinRM, et al.. Animal models of bladder outlet obstruction and molecular insights into the basis for the development of bladder disfunction. Eur Urol, 1997, 32(Suppl1): 32-39

[17] GilpinSA, GoslingJA, BarnardRJ, et al.. Morphological and morphometric studies of the human obstructed, trabeculated bladder. Br J Urol, 1985, 57(5): 525-529

[18] LevinRM, HaugaardN, O’ConnorL, et al.. Obstructive response of human bladder to BPH vs. rabbit bladder response to partial outlet obstruction: a direct comparison. Neurourol Urodyn, 2000, 19(5): 609-269

[19] BradingAF, PessinaF, EspósitoL, et al.. Effects of metabolic stress and ischaemia on the bladder and the relationship with bladder overactivity. Scand J Urol Nephrol, 2004, 215(suppl): 84-91

[20] KojimaM, InuiE, OchialA, et al.. Possible use of ultrasonically-estimated bladder weight in patients with neurogenic bladder dysfunction. Neurourol, 1996, 15(6): 641-645

[21] KojimaM, InuiE, OchiaiA, et al.. Noninvasive quantitative estimation of infravesical obstruction using ultrasonic measurement of bladder weight. J Urol, 1997, 157(2): 476-479

[22] BelalM, AbramsP. Noninvasive methods of diagnosing bladder outlet obstruction in men. Nonurodynamic approach. J Urol, 2006, 176(1): 22-28

[23] ReynardJM, YangQ, DonovanJL, et al.. The ICS-‘BPH’ Study: uroflowmetry, lower urinary tract symptoms and bladder outlet obstruction. Br J Urol, 1998, 82(5): 619-623

[24] ReynardJM, PetersTJ, LimC, et al.. The value of multiple free-flow studies in men with lower urinary tract symptoms. Br J Urol, 1996, 77(6): 813-818

[25] KuoHC. Clinical prostate score for diagnosis of bladder outlet obstruction by prostate measurements and urolowmentry. Urology, 1999, 54(1): 90-99

[26] RoehrbornCG. Male lower urinary tract symptoms (LUTS) and benign prostatic hyperplasia (BPH). Med Clin North Am, 2011, 95(1): 87-100

[27] AnderssonKE. Storage and voiding symptoms: pathophysiologic aspects. Urology, 2003, 62(Suppl2): 3-10